Pfizer Inc.
PFEEquityAI Summary
Updated 6h ago
Pfizer Inc
Pfizer Inc. (PFE) is in an unusual state of calm. Volatility is near historic lows — quieter than it has been at almost any point in recent memory. This kind of compression tends to precede a significant move, though it offers no indication of direction. For reference: Flow Score 48/100, Trend & Momentum Score 50/100.
Market Positioning
What's Happening
Pfizer locks in 2026 guidance and cost-reset targets
On 2026-05-29, Pfizer reaffirmed full-year 2026 revenue guidance of $59.5 billion to $62.5 billion and EPS guidance of $2.80 to $3.00, while also calling for operational revenue growth of about 4% at the midpoint excluding COVID-19 and LOE products. The detail that matters is the margin bridge — Pfizer is pairing top-line stabilization with $23.0 billion to $25.0 billion in combined adjusted SI&A and R&D spending, which signals the company is still leaning hard on its cost realignment program to defend earnings power.
The Bigger Picture
Pfizer is in a post-COVID reset, not a growth story yet
Guidance now matters more than headlines
Pfizer’s 2026 guide is framed around $59.5 billion to $62.5 billion of revenue and $2.80 to $3.00 of adjusted EPS, so the market is watching execution rather than narrative. The key question is whether Pfizer can hold its margin structure while it absorbs COVID normalization and LOE pressure. That makes every incremental change in cost discipline more important than the headline revenue number.
Upcoming Catalysts
Updated 3d agoPfizer often uses the weeks before earnings to reinforce guidance and shape expectations through investor communications and conference appearances. Any update that clarifies the pace of operational revenue growth or expense control could matter more than the headline itself. [6][4]
Pfizer is widely expected to report around this date based on market calendars. Investors will focus on whether the company keeps validating its 2026 revenue and EPS guide and whether cost realignment is continuing to support margins. [3][1]
Investors will watch for any management commentary that confirms the full-year revenue range of $59.5 billion to $62.5 billion and adjusted EPS of $2.80 to $3.00. The key issue is whether Pfizer can hold that frame without further reliance on one-off support from legacy product trends. [1]
Technical Analysis
Market Positioning
Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.
Key Levels
Looking at the full picture for Pfizer Inc. (PFE): extension is slightly below average (36th percentile), momentum is slightly above average (63rd percentile), flow is slightly above average (66th percentile), volatility is deeply below average — at historically low levels (3rd percentile). The standout feature is the volatility compression — the asset is unusually quiet relative to its own history. This kind of compression often precedes a significant move. The directional indicators are not extreme in either direction, which makes the volatility reading the most notable signal right now. Volatility compression at these levels rarely persists for long. A move above or below the recent range with rising volume would signal that the compression is resolving.
Where is money flowing?
Trend
Is momentum building or fading?
What is the relative strength?
How extended is this move?
Where are the key levels?
What risk am I taking?
Conclusion
The most notable thing about Pfizer Inc. (PFE) right now is the volatility compression — the asset is unusually quiet. Volatility rarely stays this low for long, and a significant move is likely building. There is not a strong signal here in either direction. This is an asset to watch rather than act on right now. A break above or below the recent range with rising volume would be the signal that the compression is resolving. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.
Your portfolio. Your context. Smarter decisions.
Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.
Personalized insights based on your actual holdings
Major market movements delivered to your inbox
Track the assets that matter most to you
No credit card required